- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05020171
Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Patients (Lambda_MIpil)
May 2, 2024 updated by: Institution de Lavigny
Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Subacute Acquired Brain Injury Patients: a Pilot Study.
The loss of lower limb strength that occurs after an Acquired Brain Injury (ABI) limits the patient's autonomy in participating in activities of daily living, including gait performance.
In the sub-acute phase, it is difficult to implement a strengthening program, as weakness prevents exercise being performed with the recommended parameters.
This limit can be exceeded by using specific robotic devices, which allow the effort provided to be adapted according to the patient's capacities.
In addition, motivation can be improved by the use of feedback or incentive games.
The aim of this pilot study is to obtain data on the effect of lower limb strength training with a seated robotic device in subacute ABI patients for a future larger randomised study.
In addition, it aims to evaluate the recruitment rate, applicability, resources for implementation and patient tolerance to the training program.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vaud
-
Lavigny, Vaud, Switzerland, 1175
- Institution de Lavigny
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Acquired Brain Injury of vascular, traumatic, infectious or tumoral origin in the subacute phase
- Walking ability ≤ Functional Ambulatory Category level 5 (1-6)
- Paresis of the lower limb: strength <57/100 on the Motricity Index
- Cognitive and memory functions allowing the patient to follow treatment instructions and give informed consent
Exclusion Criteria:
- Significant heart problem
- Venous thrombosis less than 6 months
- Musculoskeletal impairment not compatible with movement
- Degenerative neurological disease
- Oxygen-dependent
- Blood pressure not stabilized
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention group
group focus on lower limb strength training with a seated robotic device
|
2x a week during 5 weeks, strengthening of weak muscles with the intensity recommended in the literature, i.e. 3-4x15 repetition at an intensity of 50 to 80% of the maximum force combined with serious games to stimulate patient involvement in strength training
|
|
Active Comparator: control group
physiotherapy group as usual, not focused on strength training
|
2x a week during 5 weeks, active physical therapy treatment based on movement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change from study inclusion to end of intervention at 5 weeks in strength of knee extensor's
Time Frame: Study inclusion to end of intervention at 5 weeks
|
measure with a manuel dynamometer, in newton
|
Study inclusion to end of intervention at 5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change from study inclusion to end of intervention at 5 weeks in Motricity index legs
Time Frame: Study inclusion to end of intervention at 5 weeks
|
clinical manuel strength test, seating on a chair.
From 0 to 33, 33 is normal strength.
|
Study inclusion to end of intervention at 5 weeks
|
|
change from study inclusion to end of intervention at 5 weeks in timed up and go
Time Frame: Study inclusion to end of intervention at 5 weeks
|
Mobility test: standing from a chair, walking 3 meters, turn around, returning and seat. in seconds
|
Study inclusion to end of intervention at 5 weeks
|
|
change from study inclusion to end of intervention at 5 weeks in 10 meters walk test
Time Frame: Study inclusion to end of intervention at 5 weeks
|
measure of mean gait speed on 10 meters, at comfortable and maximum gait speed.
In meters/second.
|
Study inclusion to end of intervention at 5 weeks
|
|
change from study inclusion to end of intervention at 5 weeks in Ashworth Scale (spasticity)
Time Frame: Study inclusion to end of intervention at 5 weeks
|
measure of the resistance of a muscle to passive stretch according to REsistance to PASsive movement protocol.
From 0 to 4, 4 is high spasticity.
|
Study inclusion to end of intervention at 5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Claude Pichonnaz, PhD, Haute Ecole de Santé Vaud
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 20, 2021
Primary Completion (Actual)
January 29, 2024
Study Completion (Actual)
January 29, 2024
Study Registration Dates
First Submitted
August 12, 2021
First Submitted That Met QC Criteria
August 18, 2021
First Posted (Actual)
August 25, 2021
Study Record Updates
Last Update Posted (Actual)
May 3, 2024
Last Update Submitted That Met QC Criteria
May 2, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2021-00721
- 14-O20 (Other Grant/Funding Number: Commission scientifique du domaine santé HES-SO)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Group of strength training
-
Universidade Federal de Sao CarlosUnknownPatellofemoral Pain SyndromeBrazil
-
Federal University of Rio Grande do SulCompletedArterial HypertensionBrazil
-
University of WaterlooUniversity Health Network, Toronto; Canadian Institutes of Health Research... and other collaboratorsActive, not recruiting
-
Riphah International UniversityCompletedPatellofemoral PainPakistan
-
Riphah International UniversityCompletedSports Physical Therapy | Sport InjuryPakistan
-
Virginia Commonwealth UniversityRecruitingPeripheral Vascular DiseasesUnited States
-
Józef Piłsudski University of Physical EducationRecruitingStatic Stretching | Flexibility | Strength Training EffectsPoland
-
University of ZululandCompletedOsteoarthritisUnited States
-
The Hong Kong Polytechnic UniversityWest China HospitalUnknown
-
Ibadat International University, IslamabadRecruitingAthletic Performance | Neuromuscular TrainingPakistan